Effects of high doses of cholecalciferol in normal subjects: A randomized double-blinded, placebo- Controlled trial

Abstract

Background: Vitamin D repletion with high doses of vitamin D is often recommended to patients and healthy subjects. The safety, especially concerning changes in urinary calcium excretion is of great importance. Methods: In a double-blinded, placebo-controlled study in 40 healthy volunteers, we examined the changes in mineral metabolism during supplementation with 3000 IU of oral cholecalciferol daily during 4 months. Results: Both 25(OH)vitamin D and 1,25(OH) 2 vitamin D increased significantly in the active treated group as compared to the placebo group (186% versus 14% (P<0.001) and 28% versus - 8% (P<0.001)). No change was observed in urinary calcium excretion in the active group compared to the placebo group (P = 0.891). Fibroblast growth factor 23 increased significantly by 10% (P<0.018) in the active group. However, there was no difference in changes in FGF23 between treatment groups (P = 0.457). Conclusion: High dose cholecalciferol significantly increases 25(OH)vitamin D and 1,25(OH)2 vitamin D levels compared to placebo. No changes in urinary calcium excretion or other measured components of the mineral metabolism were found between groups. Trial Registration: ClinicalTrials.gov NCT00952562. © 2014 Nygaard et al.